181 related articles for article (PubMed ID: 38054758)
1. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases.
Gao X; Lin X; Wang Q; Chen J
Med Res Rev; 2024 Mar; 44(2):867-891. PubMed ID: 38054758
[TBL] [Abstract][Full Text] [Related]
2. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
3. Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges.
Tiwari MK; Chaudhary S
Med Res Rev; 2020 Jul; 40(4):1220-1275. PubMed ID: 31930540
[TBL] [Abstract][Full Text] [Related]
4. A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control.
Zhang XG; Li GX; Zhao SS; Xu FL; Wang YH; Wang W
Parasitol Res; 2014 May; 113(5):1769-73. PubMed ID: 24609234
[TBL] [Abstract][Full Text] [Related]
5. Recent pharmacological advances in the repurposing of artemisinin drugs.
Meng Y; Ma N; Lyu H; Wong YK; Zhang X; Zhu Y; Gao P; Sun P; Song Y; Lin L; Wang J
Med Res Rev; 2021 Nov; 41(6):3156-3181. PubMed ID: 34148245
[TBL] [Abstract][Full Text] [Related]
6. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives?
Li Y; Wu YL
Med Trop (Mars); 1998; 58(3 Suppl):9-12. PubMed ID: 10212890
[TBL] [Abstract][Full Text] [Related]
7. [Review of the use of artemisinin and its derivatives in the treatment of malaria].
Van der Meersch H
J Pharm Belg; 2005; 60(1):23-9. PubMed ID: 15828489
[TBL] [Abstract][Full Text] [Related]
8. Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs.
Qiu F; Liu J; Mo X; Liu H; Chen Y; Dai Z
Front Immunol; 2021; 12():751772. PubMed ID: 34567013
[TBL] [Abstract][Full Text] [Related]
9. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms.
Tong X; Chen L; He SJ; Zuo JP
Acta Pharmacol Sin; 2022 Dec; 43(12):3055-3061. PubMed ID: 36050518
[TBL] [Abstract][Full Text] [Related]
11. [Combined antimalarial therapy using artemisinin].
Majori G
Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
[TBL] [Abstract][Full Text] [Related]
12. Rectal artemisinins for malaria: a review of efficacy and safety from individual patient data in clinical studies.
Gomes M; Ribeiro I; Warsame M; Karunajeewa H; Petzold M
BMC Infect Dis; 2008 Mar; 8():39. PubMed ID: 18373841
[TBL] [Abstract][Full Text] [Related]
13. Immune suppressive properties of artemisinin family drugs.
Hou L; Huang H
Pharmacol Ther; 2016 Oct; 166():123-7. PubMed ID: 27411673
[TBL] [Abstract][Full Text] [Related]
14. [Research progress of effect of artemisinin family drugs on T lymphocytes immunomodulation].
Yan SC; Li YJ; Wang YJ; Cai WY; Weng XG; Li Q; Chen Y; Yang Q; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4992-4999. PubMed ID: 31872610
[TBL] [Abstract][Full Text] [Related]
15. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements.
Haynes RK
Curr Top Med Chem; 2006; 6(5):509-37. PubMed ID: 16719805
[TBL] [Abstract][Full Text] [Related]
16. The therapeutic potential of semi-synthetic artemisinin and synthetic endoperoxide antimalarial agents.
O'Neill PM
Expert Opin Investig Drugs; 2005 Sep; 14(9):1117-28. PubMed ID: 16144496
[TBL] [Abstract][Full Text] [Related]
17. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
18. Biological Activities of Artemisinin Derivatives Beyond Malaria.
Liu X; Cao J; Huang G; Zhao Q; Shen J
Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
[TBL] [Abstract][Full Text] [Related]
19. The immunosuppressive activity of artemisinin-type drugs towards inflammatory and autoimmune diseases.
Efferth T; Oesch F
Med Res Rev; 2021 Nov; 41(6):3023-3061. PubMed ID: 34288018
[TBL] [Abstract][Full Text] [Related]
20. Toxicity of the antimalarial artemisinin and its dervatives.
Efferth T; Kaina B
Crit Rev Toxicol; 2010 May; 40(5):405-21. PubMed ID: 20158370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
